New drug from Biogen, Eisai slows Alzheimer’s – but will it make a difference?

An experimental Alzheimer’s drug from Biogen and partner Eisai modestly slowed the brain disease’s inevitable worsening, researchers report – but it remains unclear how much difference that might make in people’s lives.